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Introduction
Renal transplantation is the chosen option by paediatricians for patients with chronic renal insufficiency (CRI) because it gives more longevity and better quality of life at a lower cost [1] . Despite transplantation, cardiovascular disease remains as one of the main causes of morbidity and mortality in children and young adults with end-stage renal disease [2] . Many well-known contributory factors such as hypertension, dyslipidaemia, hyperparathyroidism, obesity, insulin resistance, post-transplant diabetes and immunosuppressive therapy may be in cause [3, 4] . More recently, hyperhomocysteinaemia and formation of asymmetric dimethylarginine (ADMA) have been added to the list [5, 6] . Plasma homocysteine (Hcys) elevation represents an important finding since it prevails in almost 60% of patients with a renal transplant. Figure 1 shows the methylation cycle or metabolic pathway that leads from methionine to Hcys in every cell. It can be observed that an adenosyl radical group may join to methionine to form S-adenosylmethionine (SAM) which is the universal donor of the active methyl groups. This compound can transfer its methyl group to different methyl acceptors such as DNA, RNA, neurotransmitters, proteins, hormones, phosphatidylethanolamine, guanidinoacetate (GAA), cobalamin, etc. [7] . SAM is converted into S-adenosylhomocysteine (SAH), which can be reversibly hydrolyzed to form Hcys and adenosine. This part of the methylation cycle is known as 'transmethylation' [8] . Its relation with GAA and creatine (Creat) synthesis from arginine (Arg) in patients with renal transplants has been described by us in a previous work [9] .
The process of 'remethylation' of Hcys to form methionine can take place through two pathways. The first one employs betaine which transfers its methyl group to Hcys to form dimethylglycine and methionine. The second way to methylate Hcys is by means of 5-methyl-tetrahydrofolate which transfers its methyl group to Hcys by the action of the enzyme methionine synthase [10, 11] .
The metabolism of Hcys can follow other pathways, the 'trans-sulfuration', where Hcys is irreversibly transformed to cystathionine, which is degraded to cysteine. Cysteine is the precursor of glutathione and taurine, which act as antioxidant and neurotransmitter substances, respectively. This trans-sulfuration pathway can only be carried out in the liver, kidney, small intestines, pancreas and brain [12] .
Arg can follow a different methylation pathway because Arg residues within proteins can be methylated by means of protein-Arg-methyltransferases (PRMT). This methylation results in three different derivates: N-monomethyl-L-Arg, ADMA and symmetric dimethylarginine. ADMA levels depend upon dimethylarginine dimethyaminohydrolase (DDAH) activity which metabolizes ADMA to citrulline (Citr) and amines. Arg can be oxidated to Citr and nitric oxide (NO) by nitric oxide synthase (NOS). ADMA is a competitive inhibitor of NOS, and healthy, normally functioning endothelial cells depend upon the bioactivity of NO as an important physiological mediator of vascular tone and vascular structure [13] . Elevation of plasma levels of ADMA has been observed in patients with chronic kidney diseases [14] [15] [16] [17] (Figure 1 ). In this way, it is said that if ADMA levels are increased by 3-to 9-fold, it can cause an inhibition of NO formation by 30-70% [18] . So, the relation of ADMA with cardiovascular risk in renal disease incited us to study ADMA in transplanted children.
The aim of this work was to evaluate the status of the methylation cycle (SAM/SAH) and the levels of new cardiovascular biomarkers (ADMA) in children and adolescents with stable renal transplants and to establish a possible relationship between such variables and the level of renal function.
Materials and methods
Subjects
Twenty-six renal transplanted patients aged 7-18 years (17 male, 9 female) were recruited for the study. The aetiology of their chronic renal disease was mainly structural (42%) or glomerular (23%). All transplant recipients were followed up in our centre and were clinically stable at the time of the study. Inclusion criteria required that subjects had been transplanted for more than 6 years at the time of the clinical analysis. Clinical characteristics of the patients are shown in Table 1 . Exclusion criteria were the presence of hepatopathy, anuria and/or insulin-dependent diabetes mellitus. Immunosuppressive therapy combined mycophenolate mofetil with tacrolimus (23 patients), cyclosporine A with mycophenolate mofetil (1 patient), rapamycin with tacrolimus (1 patient) or rapamycin with mycophenolate mofetil (1 patient). None of the patients received treatment with folic acid, vitamin B 12 or statins.
Control values for amino acids, GAA, Creat and ADMA in plasma and for SAM and SAH in erythrocytes were determined in 30 healthy children, aged 6-18 years, who had minor surgery in our centre. Control values for amino acids, GAA and Creat in urine were obtained from 179 healthy children of both sexes attending a local school.
The study protocol was approved by the Ethics Committee of Clinic Research of Cruces Hospital, and the patient's parents gave written informed consent.
Methods
Laboratory procedures Biological data in blood and urine correspond to single sample measurements. Blood and urinary samples were taken in the morning at the time of regular visits for hospital follow-up, after an overnight fasting and before administering their daily medication. Blood samples were cooled in an ice-water bath and immediately centrifuged at 1000 g for 5 min at 4°C. The platelet-poor plasma and urine were aliquoted and stored at −40°C until the assay was performed, usually within a few days.
Cholesterol, triglycerides, vitamin B 12 , vitamin B 6 , folic acid, albumin, prealbumin, Hcys, creatinine (Cr) and β 2 -microglobulin were measured using standard laboratory techniques. Estimated glomerular filtration rate (GFR) was calculated by the Schwartz's formula [19] . The quantification of plasma and urinary amino acids was carried out with a Biochrom 30 ionic chromatograph (Gomensoro, Madrid).
The ADMA levels were determined by an inhibition ELISA kit (DLD Diagnostics, Hamburg), which required a pretreatment with acylate the samples [20] , and the final optical density was read at 450 nm using a microtiter plate reader SLT-Labinstruments EAR 400FT (Austria). To measure the remaining biochemical variables of this study, it was necessary to set specific analytical techniques.
GAA and Creat quantitation GAA and Creat in urine were quantified using a published method [21] with slight modifications, where 13 C 2 -GAA and d 3 -Creat were used as internal standards. Liquid-liquid extraction was used to isolate GAA and Creat from urine. The reactives used were saturated sodium bicarbonate, hexaflouroacetylacetone and toluene. After 2 h, the organic phases were evaporated by nitrogen at room temperature. Then, N-(tert-butyldimethylsilyl)-N-methyltrifluoroacetamide (Sigma-Aldrich, Madrid) was preferred for the derivatization of the liquid-liquid extracts instead of synthesizing the trimethylsilyl derivatives because it produced more intense and stable fragments [22] . Final samples were incubated at 80°C for 30 min. Derivated GAA and Creat were separated and quantified on a Hewlett Packard GC 6890 gas chromatograph using a Hewlett Packard 5973 mass selective detector on a capillary column HP-5MS (Supelco, Bellefonte, USA).
The procedure used for GAA and Creat quantitation in plasma consisted of a different liquid-liquid extraction, where plasma, internal standards and toluene were mixed in an Eppendorf tube [23] . After 10 min at 4°C, these tubes were centrifuged in order to evaporate organic phases by nitrogen at room temperature. Then, HCl in butanol (Regis) was added before incubating the sample at 65°C for 20 min, before a new evaporation. A mixture of acetonitrile:water (20:80) was used to reconstitute the sample. Derivated GAA and Creat were separated and quantified on a HPLC 1100 liquid chromatograph using a Triple Quad 6410 (Agilent) mass spectrometer.
SAM and SAH quantitation The reagents and solutions used for this determination were SAM p-toluenesulfonate salt, SAH and 1-methyladenosine as internal standard, purchased from Sigma (Madrid), as the rest of the reagents. Blood samples were collected from the antecubital vein into EDTA tubes, placed on ice and immediately centrifuged at 1000 g at 4°C for 5 min. Due to the instability of SAM, it is very important to use an ice bath during all the process. The erythrocyte sediment was mixed with cold perchloric acid and internal standard. The tube was vortexed until a rust brown colour was observed and allowed to precipitate for 20 min on ice. The mixture was centrifuged for 5 min and the supernatant was transferred to a new tube, to which potassium carbonate was added in order to neutralize the solution. Potassium perchlorate was allowed to precipitate for 10 min, and the tube was centrifuged for 5 min in the same conditions. Solid phase extractions (SPE) were performed on a Visiprep Supelco (Bellefonte, USA) vacuum manifold, with PBA SPE cartridge (Bond Elut), and formic acid to elute the compounds.
SAM and SAH were measured by a HPLC system consisted of an Agilent 1100 series liquid chromatograph coupled to a UV absorbance detector of the same series. SAM and SAH were separated on a Nucleosil C18 column (Teknokroma, Barcelona, Spain). The eluted compounds were detected photometrically at 254 nm.
Statistical analysis The SPSS version 16.0 was used as statistical software. Descriptive statistics were presented as median and P 3 -P 97 range. Histograms and Kolmogorov-Smirnov were made to find variables which were under a normal distribution, in order to use parametric or no parametric test. Thus, statistically significant differences between groups were analysed using Student's t-test to normal variables and Mann-Whitney test to non-normal variables.
With the purpose of determining correlations, logarithmic function was applied to non-normal variables to convert them into normal variables. Pearson coefficients were used to evaluate relationship between continuous variables and linear regression models to measure correlations between variables and the strength of their relationships. All probability values were two-tailed and the level of significance required was P < 0.05.
Results
Biochemical profile in plasma and urine
Results of biochemical profile of our patients in plasma and urine are presented in Table 2 Median value for plasma Hcys level was clearly elevated (10.0 μmol/L) (P < 0.001), and 14 of the patients (54%) showed values above the 97th percentile of controls [25] . In comparison with reference values, transplanted children presented higher erythrocyte values for SAH (P = 0.001) and lower values for SAM, indicating a statistically lower methylation capacity (P < 0.001) (Figure 2 ). It should be noted that urinary excretion of GAA and Creat was significantly lower in patients than in healthy children (P < 0.001 and P = 0.003, respectively), but values of GAA and Creat in plasma appeared to be normal. To rule out a possible deficit of GAA produc- tion, plasma levels were, as in urine, factored by plasma Cr. Plasma GAA/Cr and Creat/Cr coefficients were similar to control values (Table 3) . Transplanted patients also had higher levels of ADMA in plasma (P < 0.001) ( Figure 3) and lower values for Arg/ ADMA ratio (P = 0.001). Table 4 summarizes the statistically significant correlations observed between plasma amino acids and GAA, Creat and GFR. Levels of urinary GAA and Creat also correlated with their own levels in plasma: plasma GAA/Cr vs urinary GAA (r = 0.627, P < 0.001) and plasma Creat vs urinary Creat (r = 0.810, P < 0.001).
Correlations between parameters
In Table 5 , correlations between metabolites of methylation cycle with renal function and components of the Arg-GAA-Creat pathway are shown. Blood Hcys and SAH correlated with renal function. Plasma levels of glycine (Gly) and Citr correlated with plasma levels of GAA and Creat. Similar significant correlations were also found in urine.
The SAM/SAH ratio also had a positive correlation with plasma triglycerides (r = −0.463, P = 0.040). Moreover, cofactors of the methylation cycle such as vitamin B 6 and folic acid had positive correlations with HDLcholesterol (r = 0.563, P = 0.019 and r = −0.570, P = 0.021, respectively).
Levels of ADMA hardly correlate with the rest of variables in this study. Only ADMA correlated with urinary Cr (r = −0.449, P = 0.022), and Arg/ADMA ratio with GAA in plasma (r = 0.638, P < 0.001).
The transplanted patients were divided according to dichotomic variables such as previous dialysis, sex and high blood pressure. Previous dialysis and sex did not have any influence on continuous variables, but children with high blood pressure showed low levels of vitamin B 6 (P = 0.004) and SAM/SAH coefficient (P = 0.031). Levels of ADMA were lower but values were not statistically significant when compared to those present in patients with normal blood pressure.
Linear and multiple regression analysis
In Figures 4 and 5 , the linear regression of plasma GAA as a function of Arg/ADMA coefficient (corrected r 2 = 0.382, β = 0.009, P < 0.001) and plasma Creat as a function of urine Creat (corrected r 2 = 0.642, β = 23.4, P < 0.001) are shown, respectively.
We also found a multiple regression model in which renal function depended upon Hcys in blood and GAA in Fig. 2 . Levels of erythrocyte S-adenosylmethionine/S-adenosylhomocysteine coefficient in paediatric renal transplants in comparison with control group. urine as independent variables (corrected r 2 = 0.545, β = −61.7, P = 0.003 and β = 21.2, P = 0.025, respectively).
Discussion
This represents the first study in which the metabolic pathway from Arg to Creat and its relation with methylation cycle and plasma ADMA levels have been performed in children with stable kidney transplants. Patients received sustained treatment with several immunosuppresor drugs, but plasma immunosuppresor levels did not exert any influence since significant correlations with metabolic variables were absent.
As in a previous work [9] , we have observed significantly higher plasma levels of Gly and Citr (and Arg, but not significantly) and lower urinary excretions of Arg, Gly, Citr, GAA and Creat. The correlations found between Gly or Citr and GAA or Creat point out that these amino acids might have a higher influence on the Arg-Creat pathway than Arg itself, which is synthesized and metabolized in the kidney. These results contrast with another finding showing that GAA production was mainly dependent on Arg and Citr [26] .
Elevated levels of urinary β 2 -microglobulin were indicative of some degree of proximal renal tubular dysfunction, which could be implied in decreased renal production of GAA [27] . For these reasons, we suggest the existence of low activities of L-arginine:glycine amidinotransferase (AGAT) in the inner mitochondrial membrane of proximal renal tubular cells in transplanted patients. The normal plasma levels of GAA, despite a probable deficit of renal AGAT activity, indicate, however, that low renal underproduction of GAA, if it exists, is compensated by GAA overproduction in other organs, such as pancreas. The characteristics of extrarenal synthesis of GAA are little known and further studies should be performed on this matter [28, 29] .
Multiple regression analysis showed that renal function was independently related with Hcys in blood and GAA in urine. So, both Hcys and GAA can efficiently predict the level of GFR. In our previous investigation [9] , we wrongly concluded that low urinary excretion of Creat was a reflection of a low systemic production of this substance, due to defective methylation of GAA. This conclusion was based on the negative correlation found between plasma Hcys and urinary excretion of Creat. However, the results herein presented show normal values for plasma Creat concentration. Therefore, although plasma Creat and urinary Creat are positively related, this does not imply that low Creat excretion necessarily reflects a low systemic production of Creat. Our initial hypothesis that systemic Creat deficiency could be an additional factor for the development of neurological complications in kidney transplant recipients is no longer tenable.
The methyl group transferred to GAA to form SAH and Creat by the action of guanidinoacetate methyltransferase enzyme comes from SAM [7] . This compound and its product, SAH, induce transmethylation in the liver, so that the SAM/SAH ratio is an indication of methylation capacity. Low methylation capacity has been observed in patients with chronic renal failure [30] . The consequences could be a deficit of myelination of the central nervous system, low synthesis of neurotransmitters, alterations of properties of membranes, differences of genetic expression, etc. In the present investigation, transplanted patients, with only slightly abnormal renal function, also had high levels of SAH and low SAM/SAH ratio, as evidence of diminished methylation capacity.
Although high levels of SAH may affect both remethylation and trans-sulfuration of Hcys, we did not find any correlations between SAH or SAM/SAH in erythrocytes and Hcys in plasma. Plasma Hcys reflects the amount of the metabolite which is transported to tissues and organs, whereas erythrocytes SAM and SAH are more indicative of storage and liver metabolism. In this way, SAH may be considered as a more sensitive indicator of renal insufficiency and cardiovascular disease than Hcys itself [31] [32] [33] . In our study, both SAH and Hcys correlated negatively with GFR and positively with plasma Cr. These results favour the theory that increased plasma levels of Hcys in patients with reduced renal function are due to an alteration of the methylation cycle, particularly present at low values of glomerular filtration [34] . At this point, the connection with lipid metabolism should be mentioned since SAM/ SAH ratio had a positive correlation with plasma triglycerides and cofactors of methylation cycle such as vitamin B 6 and folic acid had positive correlations with HDL-cholesterol. LDL-cholesterol can modulate the expression of PRMT and lead to elevated ADMA concentrations [35] , but LDL-cholesterol levels were normal in transplanted patients, so other reasons may explain the low activity of DDAH and accumulation of ADMA.
Furthermore, there was a relation of the methylation cycle and Arg-Creat pathway. Plasma Hcys correlated positively with plasma Citr and Gly and plasma GAA and Creat levels factored by Cr correlated positively with SAM/SAH and negatively with Hcys. These relationships may have great importance because synthesis of GAA mainly takes place in the kidney which is also the major site of SAH disposal in humans [36] .
Approximately 10-fold more Arg is metabolized to Creat than is used for NO synthesis. If the conversion to GAA is impaired, the accumulation of Arg and its derivative ADMA will compromise activity of NOS and reduce the formation of NO. ADMA levels appear significantly elevated in renal transplanted patients, although not as much as in patients with advanced CRI [37, 38] . Although there is a direct relation between ADMA production and renal function [39, 40] , this study proves that elevated plasma levels of ADMA may also be present in patients with only slightly increased values of plasma Cr.
The presence of a relationship between ADMA production and Arg-Creat pathway was supported by the positive correlation found between Arg/ADMA ratio and plasma GAA. The diminished Arg/ADMA ratio is indicative of a high cardiovascular risk because it reflects that Arg absorbed by renal tubular and endothelial cells is greatly used for ADMA production [41] . As shown in the linear regression model, as more GAA is synthesized by AGAT enzyme a higher Arg/ADMA ratio will ensue giving as a result a decreased risk for development of atherosclerosis.
Hyperhomocysteinaemia itself could also cause accumulation of ADMA because Hcys influences the activity of the DDAH enzyme which degrades ADMA to Citr and amines. The union of Hcys and DDAH modifies the spatial configuration of the enzyme inhibiting its activity [42] . Moreover, the high biochemical reactivity of Hcys could release methylated Arg from proteins giving molecules of ADMA. However, in this investigation, ADMA levels did not correlate with Hcys levels, indicating that ADMA behaved as an independent biomarker for cardiovascular risk prediction [43] . So, activity of DDAH enzyme or levels of dimethylamine to see the process of ADMA degradation, and nitrates-nitrites to check a diminished production of NO [18] should be studied in further studies about renal transplants in order to consider NO metabolism as a whole (DDAH activity, NOS activity, nitrates, nitrites or dimethylamine). In the present study, the optimization of blood sample amounts in these children and the fact that urines were not adequately stored prevent developing new methods, such as nitrates and nitrites in urine, where samples should be stored in a proper medium to stabilize nitrite and prevent bacterial reduction of nitrate to nitrite.
Transplanted patients with high blood pressure showed low levels of vitamin B 6 and SAM/SAH ratio. Vitamin B 6 diminishes the content in plasma Hcys by means of transsulfuration with rise of SAM/SAH ratio. However, in our study, levels of vitamin B 6 did not correlate either with plasma Hcys or with SAM/SAH ratio. A deficit of vitamin B 6 could also induce a deficit of glutathione (Figure 1 ), which is a potent antioxidant related to childhood hyper- tension [44] . All cofactors of the methylation cycle (folate, vitamins B 6 and B 12 ) evidenced normal levels in normotensive patients, and no correlations were found with Hcys or other components of the metabolic pathways.
Finally, some speculations may be raised about the possibility that some preventive measures would contribute to ameliorate the cardiovascular risk in children and adolescents with renal transplant. As mentioned above, Creat supplementation is not necessary to correct a systemic Creat deficiency but it may contribute to lower plasma Hcys levels despite its lack of influence on human methylation [45] . Pharmacological increase of folic acid and vitamin B 6 and B 12 levels may enhance remethylation and trans-sulfuration of Hcys and diminish SAH concentration. Theoretically, in cases with high plasma ADMA level, a supplementation with Arg would enhance NO synthesis and reduce endothelial inflammation. However, these patients already have elevated levels of Arg and Citr in plasma, so Arg supplementation would have more adverse than beneficial effects. Other possible means are the administration of antioxidants (statins, vitamin E) or of N-acetylcysteine which combines with Hcys and activates DDAH enzyme.
We conclude that children and adolescents with renal transplants, even with only moderately decreased renal function, present disturbances in the methylation cycle and Arg-Creat pathway which lead to elevated plasma values of Hcys, SAH and ADMA. Defective methylation and impaired production of NO will contribute to the endothelial dysfunction observed in renal transplanted patients. The possible benefit of appropriate therapeutic measures is a matter of further investigation.
